Skip to main content
. 2018 Apr;10(4):2295–2302. doi: 10.21037/jtd.2018.03.124

Table 1. Clinical characteristics of the study and control group.

Clinical characteristics Study group (n=25) Control group (n=25) P
Male subjects 18 (72.0) 21 (84.0) 0.306
Age, years 65.5±16.4 64.1±15.4 0.757
Witnessed 14 (56.0) 14 (56.0) 1.000
Bystander CPR 17 (68.0) 19 (76.0) 0.529
Prehospital rhythm 0.196
   Shockable 7 (28.0) 3 (12.0)
   Unshockable 18 (72.0) 21 (84.0)
   Unknown 0 (4.0) 1 (4.0)
Comorbidity
   Any comorbidities 20 (80.0) 20 (80.0) 1.000
   Hypertension 13 (52.0) 12 (48.0) 0.777
   Diabetes 8 (32.0) 7 (28.0) 0.758
   Coronary artery disease 4 (16.0) 9 (36.0) 0.107
   Cerebrovascular accident 1 (1.0) 4 (16.0) 0.349
   Chronic renal failure 2 (8.0) 2 (8.0) 1.000
   Chronic lung disease 3 (12.0) 1 (4.0) 0.609
   Chronic liver disease 0 (0.0) 1 (4.0) 1.000
   Active cancer 1 (4. 0) 5 (20.0) 0.189
Initial rhythm 0.147
   VF/pulseless VT 0 (0.0) 2 (8.0)
   PEA 2 (8.0) 4 (16.0)
   Asystole 23 (92.0) 19 (76.0)
Time factors
   Prehospital CPR time 22.7±7.1 21.8±9.2 0.720

Data are presented as n (%) or mean with standard deviation. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity.